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Background
The beneficial effects of physical activity (PA) on normal
growth and development of children and adolescents
have been widely recognised. We explore physical activity
(PA) in adolescents with JIA in comparison with a healthy
population.
Materials and methods
Patients eligible for this study were patients attending an
adolescent JIA outpatient clinic. Total energy expenditure
(TEE), Activity-related energy expenditure (AEE), Physical
activity level (PAL) and Physical activity pattern (PAP)
were assessed with a 3-day activity diary. Reference data
were collected from healthy Dutch Secondary School
Children.
Results
Thirty patients and 106 controls were included; mean (±
SD) age in years was 17.0 (± 0.6) and 16.7 (± 0.9), respec-
tively. TEE, AEE and PAL were significantly lower in the
JIA group (Table 1) compared to the normal population.
The JIA group spent more time in bed and less time on
moderate to vigorous PA. 23% of the JIA patients met
public health recommendations to perform daily one
hour or more of moderate to vigorous PA, compared to
66% in the reference group.
Conclusion
Adolescents with JIA have low PA levels and are therefore
at risk of losing the benefits of PA. Interventions by paedi-
atric rheumatologists are needed to increase PA levels in
patients with JIA.
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Table 1: 
JIA (mean ± SD) Controls (mean ± SD) p value
TEE (mega joule.day-1) 12.17 (± 3.38) 14.48 (± 3.38) <0.01
AEE (mega joule.day-1) 3.99 (± 2.20) 6.12 (± 2.58) <0.01
PAL (TEE/BMRp) 1.74 (± 0.29) 2.09 (± 0.39) <0.01